0001566045-19-000004.txt : 20191105 0001566045-19-000004.hdr.sgml : 20191105 20191105144206 ACCESSION NUMBER: 0001566045-19-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191101 FILED AS OF DATE: 20191105 DATE AS OF CHANGE: 20191105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stanley Rhonda L. CENTRAL INDEX KEY: 0001566045 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-13789 FILM NUMBER: 191192877 MAIL ADDRESS: STREET 1: 5001 SOUTH MIAMA BOULEVARD STREET 2: SUITE 300 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adhera Therapeutics, Inc. CENTRAL INDEX KEY: 0000737207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112658569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-578-5901 MAIL ADDRESS: STREET 1: 4721 EMPEROR BOULEVARD STREET 2: SUITE 350 CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Marina Biotech, Inc. DATE OF NAME CHANGE: 20100722 FORMER COMPANY: FORMER CONFORMED NAME: MDRNA, Inc. DATE OF NAME CHANGE: 20080610 FORMER COMPANY: FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC DATE OF NAME CHANGE: 19920703 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-11-01 0 0000737207 Adhera Therapeutics, Inc. ATRX 0001566045 Stanley Rhonda L. C/O ADHERA THERAPEUTICS, INC. 4721 EMPEROR BLVD., SUITE 350 DURHAM NC 27703 0 1 0 0 SVP Finance & Accounting Options to purchase common stock 0.09 2019-11-01 4 A 0 350000 0 A 2029-11-01 common stock 350000 350000 D Options to purchase 75,000 shares are exercisable immediately, options to purchase 75,000 shares shall vest on each of November 1, 2020, November 1, 2021 and November 1, 2022, options to purchase 25,000 shares shall vest on such date (if any) that the Issuer determines that the "Revenue Target" (as defined in the Employment Agreement dated October 29, 2019 between the Issuer and the reporting person (the "Employment Agreement")) is achieved, and options to purchase 25,000 shares shall vest on such date (if any) that the Issuer determines that the "Stock Price Target" (as defined in the Employment Agreement) has been achieved. /s/ Rhonda Stanley 2019-11-05